Healthcare
Redevelopment begins at Port Macquarie Private Hospital
Redevelopment begins at Port Macquarie Private Hospital
It is expected to be completed by April 2026.
Perennial to launch Shanghai’s first wholly foreign-owned tertiary hospital
The project is expected to carry a total investment cost of $69.4m (RMB500m).
Builder appointed for $61.3m Temora Hospital redevelopment
The project is expected to be completed in 2028.
APAC to see highest growth in global medical displays market
Thanks to increased investments and an ageing population.
SGH develops AI chatbot to support perioperative assessments
It allows doctors to input patient information from electronic health records.
AIG Hospitals leverages ‘HemoPill’ for real-time GI bleed detection
The non-invasive capsule wirelessly transmits data to clinicians.
Gleneagles, Faezah Healthcare partner to boost care in Sabah
Key areas include clinical development and brand engagement.
IHH Healthcare to drive digital transformation across key markets
The initiative focuses on Singapore, Malaysia, and India.
FV Hospital uses shockwave tech for hardened arteries
IVL is integrated into a coronary intervention workflow.
Vinmec Central Park performs SEEG using robotic guidance system
The tech allowed for shorter operative time and reduced brain trauma.
Asian Hospital unveils CyberKnife for targeted cancer treatment
The technology enables real-time, image-guided radiation therapy.
Korea University Medicine’s wireless system supports smart hospital push
The solution integrates real-time location systems.
MedPark Hospital signs MoU with Korean Association in Thailand
The agreement will focus on addressing language and cultural barriers.
Emergency care benefit launched at Philippines’ St. Elizabeth Hospital
Eligible patients will receive care without requiring hospital admissions.
Upgrades underway for Australia’s Maryborough Hospital
A new forecourt and patient drop-off zone are being built.
7MM triple-negative breast cancer market eyes 4.7% CAGR growth until 2034
The sector’s expansion is attributed to rising incidence rates.
Biologic therapeutic market to hit $794.5b by 2029
Thanks to the demand for monoclonal antibodies, gene and cell therapies, and vaccines.